N-acetylcysteine
N-acetylcysteine is a dietary supplement with 177 clinical trials. Currently 15 active trials ongoing. Historical success rate of 84.9%.
Success Metrics
Based on 107 completed trials
Phase Distribution
Phase Distribution
39
Early Stage
59
Mid Stage
48
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.3%
107 of 130 finished
17.7%
23 ended early
15
trials recruiting
177
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Assessment of the Impact of N-acetylcysteine Supplementation on Physical Performance
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
Clinical Trials (177)
Assessment of the Impact of N-acetylcysteine Supplementation on Physical Performance
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
Oral N-acetylcysteine for Retinitis Pigmentosa
A Study of N-acetylcysteine in Patients With COVID-19 Infection
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC)
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
Therapeutics for Moderate and Severe Dengue
Effects of NAC on Symptoms of CHR Patients
Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Tolerability of Enteral NAC in Infants
Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)
Efficacy & Safety of Dry Powder Ivy Extract (Syrup Prospan) Versus NAC Among COPD Patients
Prevention of Serious Adverse Events Following Angiography
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 177